- Home
- ADIL vs NCPL Comparison
ADIL vs NCPL Comparison
Compare ADIL & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- NCPL
- Stock Information
- Founded
- ADIL 2010
- NCPL 1984
- Country
- ADIL United States
- NCPL United States
- Employees
- ADIL N/A
- NCPL N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- NCPL Investment Managers
- Sector
- ADIL Health Care
- NCPL Finance
- Exchange
- ADIL Nasdaq
- NCPL Nasdaq
- Market Cap
- ADIL 4.8M
- NCPL 3.9M
- IPO Year
- ADIL 2018
- NCPL N/A
- Fundamental
- Price
- ADIL $0.79
- NCPL $2.29
- Analyst Decision
- ADIL Strong Buy
- NCPL
- Analyst Count
- ADIL 1
- NCPL 0
- Target Price
- ADIL $8.00
- NCPL N/A
- AVG Volume (30 Days)
- ADIL 172.8K
- NCPL 87.6K
- Earning Date
- ADIL 03-31-2025
- NCPL 03-17-2025
- Dividend Yield
- ADIL N/A
- NCPL N/A
- EPS Growth
- ADIL N/A
- NCPL N/A
- EPS
- ADIL N/A
- NCPL N/A
- Revenue
- ADIL N/A
- NCPL $1,702,723.00
- Revenue This Year
- ADIL N/A
- NCPL N/A
- Revenue Next Year
- ADIL N/A
- NCPL $101.16
- P/E Ratio
- ADIL N/A
- NCPL N/A
- Revenue Growth
- ADIL N/A
- NCPL N/A
- 52 Week Low
- ADIL $0.72
- NCPL $1.41
- 52 Week High
- ADIL $4.17
- NCPL $22.82
- Technical
- Relative Strength Index (RSI)
- ADIL 40.52
- NCPL 56.78
- Support Level
- ADIL $0.76
- NCPL $2.09
- Resistance Level
- ADIL $0.85
- NCPL $2.45
- Average True Range (ATR)
- ADIL 0.05
- NCPL 0.13
- MACD
- ADIL 0.01
- NCPL 0.01
- Stochastic Oscillator
- ADIL 50.77
- NCPL 58.66
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.